This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

CVS/pharmacy Partners With St. Jude Children's Research HospitalA® For Thanks And GivingA® Campaign

WOONSOCKET, R.I., Nov. 18, 2013 /PRNewswire/ --  CVS/pharmacy today announced its annual in-store fundraiser for the tenth year to support the St. Jude Children's Research Hospital Thanks and Giving campaign, a unique holiday program to raise awareness and funds for the pioneering research and exceptional care provided at St. Jude. Since the campaign's inception, CVS/pharmacy and its customers have raised more than $37 million to support St. Jude, which is leading the way the world understands, treats and defeats childhood cancer and other deadly diseases.

(Logo: http://photos.prnewswire.com/prnh/20100816/NE50800LOGO )

Through Dec. 7, CVS Caremark colleagues will encourage customers to add $1 or $3 to their purchase at the register to support the campaign.  Customers shopping online at www.CVS.com/StJude  will also have the opportunity to donate $1 at checkout.  

"The incredible support we receive from CVS/pharmacy and their loyal customers during the St. Jude Thanks and Giving campaign is critical in our fight to end childhood cancer," said Marlo Thomas, national outreach director for St. Jude and daughter of hospital founder Danny Thomas. "St. Jude is where doctors send some of their toughest cases, because we have the world's best survival rates.  CVS/pharmacy's commitment helps us continue that lifesaving work while staying true to my father's founding promise that families never receive a bill from St. Jude for treatment, travel, housing and food – because all a family should worry about is helping their child live."

Funds raised by CVS/pharmacy customers and colleagues during the Thanks and Giving campaign support the CVS Caremark Rehabilitation Services Center at St. Jude.  Children with deadly diseases such as cancer may experience developmental, cognitive or physical impairments because of their illnesses as well as the treatments used to save their lives.  The facility in Memphis, Tenn., which opened in 2009, doubled the space dedicated to providing audiology, occupational therapy, physical therapy and speech-language pathology services to St. Jude patients to help them overcome barriers they face in recovery.

"CVS/pharmacy is proud of its customers and colleagues who for nearly a decade have made a significant impact in the lives of children living with cancer and other deadly diseases through their generous support of the Thanks and Giving campaign," said Eileen Howard Boone, Senior Vice President of Corporate Philanthropy and Social Responsibility, CVS Caremark.  "As a pharmacy innovation company committed to helping people on their path to better health, we commend St. Jude Children's Research Hospital for all the work they are doing to treat children with cancer and the lifesaving research they share with experts across the world to help find cures."

In 2012, CVS/pharmacy customers and colleagues raised nearly $6.4 million nationwide in support of the St. Jude Children's Research Hospital Thanks and Giving Campaign and more than $37 million since 2004.

About St. Jude Children's Research Hospital®St. Jude Children's Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other deadly diseases. St. Jude has the world's best survival rates for the most aggressive childhood cancers, and treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since we opened more than 50 years ago. St. Jude is working to drive the overall survival rate for childhood cancer to 90 percent in the next decade. St. Jude freely shares the breakthroughs we make, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food – because all a family should worry about is helping their child live. Join the St. Jude mission by visiting stjude.org or following St. Jude on facebook.com/stjude and twitter.com/stjude.

About CVS CaremarkCVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,500 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 60 million plan members; and its retail health clinic system, the largest in the nation with more than 650 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans. As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases such as diabetes obtain and stay on their medications. Find more information about how CVS Caremark is reinventing pharmacy for better health at info.cvscaremark.com.

About CVS/pharmacyCVS/pharmacy, the retail division of CVS Caremark Corporation (NYSE: CVS), is America's leading retail pharmacy with more than 7,500 CVS/pharmacy and Longs Drug stores. CVS/pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com. General information about CVS/pharmacy and CVS Caremark is available at  http://info.cvscaremark.com.

Contact: Joanne DwyerCVS/pharmacy401.770.2898 JDwyer@cvs.com

SOURCE CVS/pharmacy

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs